Inhibitors for the blood-clotting factor Xa

Details Inhibitors for the blood-clotting factor Xa Inhibitors for the blood-clotting factor Xa

2005-01-11

2005-01-11

Kumar, Shailendra (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Amino nitrogen containing

C564S032000, C564S047000, C564S056000, C564S123000, C564S152000, C564S155000, C514S588000, C514S590000, C514S616000, C514S478000, C560S024000

Reexamination Certificate

active

06841701

ABSTRACT:
The invention relates to derivatives of amidino-benzylamine, especially derivatives of 4-amidino-benzylamine, with two bonded amino acids. These derivatives represent a novel group of highly active and very selective F Xa-inhibitors for treating cardiovascular diseases and thrombotic events.

REFERENCES:
patent: 5705487 (1998-01-01), Schacht et al.
patent: 5707966 (1998-01-01), Schacht et al.
patent: 5710130 (1998-01-01), Schacht et al.
patent: 5726159 (1998-03-01), Schacht et al.
patent: 5914319 (1999-06-01), Schacht et al.
patent: WO 9429336 (1994-12-01), None
patent: WO 9529189 (1995-11-01), None
patent: WO 9625426 (1996-08-01), None
patent: WO 0058346 (2000-10-01), None
CA:137:134463 abs of Bioorganic & Med Chem Letters by Kunzel et al 12(4) pp645-648 2002.*
CA:133:267159 abs of WO 2000058346 Oct. 5, 2000.*
Bookser et al., “Syntheses of Quadruply Two-and Three-Atom, Aza-Bridged, Cofacial Bis (5,10,15,20-Tetraphenylporphyrins),”J. Am. Chem. Soc.113:4208-4218 (1991).
Gustafsson et al., “Effects of Inogatran, A New Low-Molecular-Weight Thrombin Inhibitor, in Rat Models of Venous and Arterial Thrombosis, Thrombolysis and Bleeding Time,”Blood Coagulation and Fibrinolysis7:69-79 (1996).
Hara et al., “DX-9065a, a New Synthetic, Potent Anticoagulant and Selective Inhibitor For Factor Xa,”Thrombosis and Haemostasis71:314-319 (1994).
Herbert et al., “DX 9065A, A Novel, Synthetic, Selective and Orally Active Inhibitor of Factor Xa: In Vitro and In Vivo Studies,”The Journal of Pharmacologically and Experimental Therapeutics276:1030-1038 (1996).
Ho et al., “Exploratory Solid-Phase Synthesis of Factor Xa Inhibitors: Discovery and Application of P3-Heterocyclic Amides as Novel Types of Non-Basic Arginine Surrogates,”Bioorganic&Medicinal Chemistry Letters9:3459-3464 (1999).
Judkins et al., “A Versatile Synthesis of Amidines from Nitriles Via Amidoximes,”Synthetic Communications26:4351-4367 (1996).
Kettner et al., “The Selective Affinity Labeling of Factor XaBy Peptides or Arginine Chloromethyl Ketone,”Thrombosis Research22:645-652 (1981).
Maduskuie et al., “Rational Design and Synthesis of Novel, Potent Bis-Phenylamidine Carboxylate Factor Xa Inhibitors,”J. Med. Chem.41:53-62 (1998).
Mohan et al., “Solid-Phase Synthesis of N-Substituted Amidinophenoxy Pyridines as Factor XA Inhibitors,”Bioorganic&Medicinal Chemistry Letters8:1877-1882 (1998).
Ostrem et al., “Discovery of a Novel, Potent, and Specific Family of Factor Xa Inhibitors via Combinatorial Chemistry,”Biochemistry37:1053-1059 (1998).
Phillips et al., “Discovery of N-[2-[5-[Amino(imino) Methyl]-2 Hydroxyphenoxy]-3,5-Difluoro-6-[3-(4,5-Dihydro-1-Methyl-1H-Imidazol-2-yl) Phenoxy] Pyridin-4-yl]-N-Methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa1,”J. Med. Chem.41:3557-3562 (1998).
Quan et al., “Bisbenzamidine Isoxazoline Derivatives as Factor Xa Inhibitors,”Bioorganic&Medicinal Chemistry Letters7:2813-2818 (1997).
Sato et al., “YM-60828, A Novel Factor Xa Inhibitor: Separation of its Antithrombotic Effects From its Prolongation of Bleeding Time,”European Journal of Pharmacology339:141-146 (1997).
Sato et al., “Antithrombotic Effects of YM-60828, a Newly Synthesized Factor Xa Inhibitor, in Rat Thrombosis Models and its Effects on Bleeding Time,”British Journal of Pharmacology123:92-96 (1998).
Sperl et al., “Urethanyl-3-Amidinophenylalanine Derivatives as Inhibitors of Factor Xa. X-Ray Crytstal Structure of a Trypsin/Inhibitor Complex and Modeling Studies,”Biol. Chem.381:321-329 (2000).
Sturzebecher et al., “Synthetic Inhibitors of Bovine Factor Xa and Thrombin Comparison of Their Anticoagulant Efficiency,”Thrombosis Research54:245-252 (1989).
Tucker et al., “Potent Noncovalent Thrombin Inhibitors that Utilize the Unique Amino Acid D-Dicyclohexylalanine in the P3 Position. Implications on Oral Bioavailability and Antithrombotic Efficacy,”J. Med. Chem.40:1565-1569 (1997).
Wagner et al., “Synthese von N-[Amidinobenzyl]-und N-[Amidinophenyl]-Phthalimide und-1-Oxoisoindoline,”Pharmazie32:76-79 (1977).

Affiliated with

Also associated with

Rating

Inhibitors for the blood-clotting factor Xa does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors for the blood-clotting factor Xa, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors for the blood-clotting factor Xa will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3367603